Business News/Market/Market Stats/   Aurobindo Pharma share price
Mutual Fund Ownership
Ownership as on: Wed, 4 Oct, 2023

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)50.72
% of AUM7.70%

Quant Large and Mid Cap Fund Growth

4/5
Other
Amount Invested (Cr.)72.05
% of AUM6.97%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)34.89
% of AUM6.70%

Mirae Asset Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)120.14
% of AUM6.63%

Tata Equity Savings Regular Growth

2/5
Hybrid
Amount Invested (Cr.)7.67
% of AUM5.80%

Aurobindo Pharma SUMMARY

Aurobindo Pharma is trading -3.32% lower at Rs 878.00 as compared to its last closing price. Aurobindo Pharma has been trading in the price range of 909.40 & 871.15. Aurobindo Pharma has given 107.31% in this year & 4.01% in the last 5 days.

 

Aurobindo Pharma has TTM P/E ratio 21.55 as compared to the sector P/E of 21.97.There are 25 analysts who have initiated coverage on Aurobindo Pharma. There are 6 analysts who have given it a strong buy rating & 9 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.

 

The company posted a net profit of 570.75 Crores in its last quarter.

 

Listed peers of Aurobindo Pharma include Aurobindo Pharma (-3.32%), Pfizer (-0.08%), Astrazeneca Pharma India (-0.91%) etc.

FAQs about Aurobindo Pharma share price

Aurobindo Pharma is trading at 878.00 as on Wed Oct 04 2023 07:44:41. This is -3.32% lower as compared to its previous closing price of 908.15.

The market capitalization of Aurobindo Pharma is 51445.41 Cr as on Wed Oct 04 2023 07:44:41.

The average broker rating on Aurobindo Pharma is Buy. The breakup of analyst rating is given below -

  • 6 analysts have given a strong buy rating
  • 9 analysts have given a buy rating
  • 7 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 2 analysts have given a strong sell rating

The 52 wk high for Aurobindo Pharma is 930.00 whereas the 52 wk low is 397.30

Aurobindo Pharma can be analyzed on the following key metrics -

  • TTM P/E: 21.55
  • Sector P/E: 21.97
  • Dividend Yield: 0.33%
  • D/E ratio: -

Aurobindo Pharma reported a net profit of 1927.50 Cr in 2023.

Recommended For You
Trending Stocks
22,755.45+417.30(1.87%)
1,522.20+14.25(0.94%)
2,493.05+22.90(0.93%)
999.30-40.70 (-3.91%)
233.85-7.30 (-3.03%)